Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,129 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical impact of CD25 expression on outcomes of allogeneic hematopoietic stem cell transplant for cytogenetically intermediate-risk acute myeloid leukemia.
Ikegawa S, Doki N, Yamamoto K, Shingai N, Takahashi Y, Aoki J, Yoshioka K, Narukawa K, Ishida S, Igarashi A, Oshikawa G, Kobayashi T, Kakihana K, Sakamaki H, Haraguchi K, Okuyama Y, Ohashi K. Ikegawa S, et al. Among authors: yoshioka k. Leuk Lymphoma. 2015 Jun;56(6):1874-7. doi: 10.3109/10428194.2014.974044. Epub 2014 Nov 14. Leuk Lymphoma. 2015. PMID: 25311493 No abstract available.
Toxic encephalopathy after exposure to azacitidine.
Watanabe K, Doki N, Miura Y, Hagino T, Kurosawa S, Hino Y, Shingai N, Yoshioka K, Ishida S, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K. Watanabe K, et al. Among authors: yoshioka k. Leuk Lymphoma. 2015 May;56(5):1538-9. doi: 10.3109/10428194.2014.964701. Epub 2014 Nov 5. Leuk Lymphoma. 2015. PMID: 25224457 No abstract available.
Central Nervous System Involvement at the Time of Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with a Poor Outcome in Patients with Acute Myeloid Leukemia.
Ikegawa S, Doki N, Kaito S, Kurosawa S, Sakaguchi M, Harada K, Yamamoto K, Hino Y, Shingai N, Senoo Y, Watanabe D, Hagino T, Yoshioka K, Watakabe K, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K. Ikegawa S, et al. Among authors: yoshioka k. Pathol Oncol Res. 2017 Apr;23(2):433-437. doi: 10.1007/s12253-016-0162-6. Epub 2016 Dec 21. Pathol Oncol Res. 2017. PMID: 28004352 Free article.
Outcome of allogeneic hematopoietic stem cell transplantation for T-cell lymphoblastic leukemia/lymphoma: A single-center study.
Yasuda S, Najima Y, Konishi T, Yamada Y, Nagata A, Takezaki T, Kaito S, Kurosawa S, Sakaguchi M, Harada K, Shingai N, Yoshioka K, Inamoto K, Mukae J, Toya T, Igarashi A, Shimizu H, Kobayashi T, Kakihana K, Sakamaki H, Kawamata N, Ohashi K, Doki N. Yasuda S, et al. Among authors: yoshioka k. Leuk Res. 2021 Sep;108:106627. doi: 10.1016/j.leukres.2021.106627. Epub 2021 May 18. Leuk Res. 2021. PMID: 34062327
[Chronic myeloid leukemia relapsing ten years after allogenic bone marrow transplantation].
Hino Y, Doki N, Yamamoto K, Senoo Y, Sasajima S, Sakaguchi M, Hattori K, Kaito S, Kurosawa S, Harada K, Ikegawa S, Watanabe D, Hagino T, Yoshioka K, Watakabe K, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K. Hino Y, et al. Among authors: yoshioka k. Rinsho Ketsueki. 2016 May;57(5):608-12. doi: 10.11406/rinketsu.57.608. Rinsho Ketsueki. 2016. PMID: 27263786 Japanese.
Comparison of transplant outcomes and economic costs between biosimilar and originator filgrastim in allogeneic hematopoietic stem cell transplantation.
Harada K, Yamada Y, Konishi T, Nagata A, Takezaki T, Kaito S, Kurosawa S, Sakaguchi M, Yasuda S, Yoshioka K, Watakabe-Inamoto K, Igarashi A, Najima Y, Hagino T, Muto H, Kobayashi T, Doki N, Kakihana K, Sakamaki H, Ohashi K. Harada K, et al. Among authors: yoshioka k. Int J Hematol. 2016 Dec;104(6):709-719. doi: 10.1007/s12185-016-2085-0. Epub 2016 Aug 26. Int J Hematol. 2016. PMID: 27565504
Central nervous system infection following allogeneic hematopoietic stem cell transplantation.
Hanajiri R, Kobayashi T, Yoshioka K, Watanabe D, Watakabe K, Murata Y, Hagino T, Seno Y, Najima Y, Igarashi A, Doki N, Kakihana K, Sakamaki H, Ohashi K. Hanajiri R, et al. Among authors: yoshioka k. Hematol Oncol Stem Cell Ther. 2017 Mar;10(1):22-28. doi: 10.1016/j.hemonc.2016.08.008. Epub 2016 Sep 17. Hematol Oncol Stem Cell Ther. 2017. PMID: 27664550 Free article.
[Donor cell leukemia with bone marrow necrosis].
Ikegawa S, Najima Y, Sano N, Horiguchi SI, Kaito S, Kurosawa S, Sakaguchi M, Harada K, Hino Y, Yamamoto K, Senoo Y, Watanabe D, Yoshioka K, Watakabe K, Igarashi A, Doki N, Kobayashi T, Kakihana K, Sakamaki H, Hishima T, Ohashi K. Ikegawa S, et al. Among authors: yoshioka k. Rinsho Ketsueki. 2016;57(11):2334-2338. doi: 10.11406/rinketsu.57.2334. Rinsho Ketsueki. 2016. PMID: 27941282 Japanese.
[Retrospective analysis of clinical outcomes of the patients with chronic myeloid leukemia who stopped administration of tyrosine kinase inhibitors: a single institution experience].
Senoo Y, Yoshioka K, Kaito S, Kurosawa S, Harada K, Yamamoto K, Hino Y, Sakaguchi M, Ikegawa S, Watanabe D, Watakabe K, Hagino T, Igarashi A, Najima Y, Doki N, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K. Senoo Y, et al. Among authors: yoshioka k. Rinsho Ketsueki. 2016;57(12):2481-2489. doi: 10.11406/rinketsu.57.2481. Rinsho Ketsueki. 2016. PMID: 28090014 Japanese.
2,129 results